As enrollment shifts, protocols evolve, and studies expand globally, agile forecasting and inventory strategies help ensure product availability while reducing waste.
- Optimizing CMO/CRO Partnerships To Improve Clinical Trial Supply Performance
- Unlocking The Value Of Real-World Data In Global Clinical Trials
- Clinical Supply Chain Continuity And Resilience
- Mastering Temperature Control And Advanced Therapy Logistics In Global Clinical Supply Chains
- How AI Can Solve Poor Communication Across Clinical Trial Supply Chains
- Invisible Yet Accountable: How Clinical Supply Pressures Build Strategic Leaders
- From Invisible to Integral: Inviting Clinical Supply Expertise to the Planning Table
- Managing Supply Disruptions In ATIMP Clinical Trials
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Unblinding Risks In RTSM: What's Still Going Wrong, And How Korio Fixes It
Protecting study integrity requires more than just luck. Learn how systemic gaps lead to unintentional unblinding and how a proactive, engine-based approach can safeguard your clinical data.
-
The Crucial Role Of IRT/RTSM In Optimizing Drug Supply Budgets
Expand your knowledge of IRT/RTSM systems and their capabilities to tailor supplies to site-specific recruitment, significantly decrease drug waste and costs, ensure efficient IMP management, and more.
-
What Are Decentralized Clinical Trials (DCTs)?
Discover how DCTs leverage “virtual” tools, such as telemedicine, sensory-based technologies, wearable medical devices, and direct delivery of study drugs and materials to patients’ homes.
-
Logistics, Transport Challenges Require Complex Solutions
The pandemic created additional obstacles for the clinical supply chain. Ensuring continued clinical trial operation requires an optimal management solution for clinical material supply.
-
Transportation Solutions For Cell And Gene Therapy Supply Chains
Developing a strong supply chain for your cell and gene therapy can make your company a more attractive target for acquisition as well as a more competitive player in the commercial environment.
-
Building Robust Clinical Supply Chains To Support Global Trials
Ensuring drugs reach patients at the right time and place is crucial. Review key areas to consider as you build a robust clinical supply chain that supports global trials effectively and efficiently.
-
Treating Deficiencies In Employee Training And Mentorship
Investing in employee training and development is not just beneficial for the employees. It also contributes significantly to the organization’s success and competitive advantage.
-
Finding An RTSM Software To Keep Up With A Small Biotech
Stop letting rigid RTSM builds stall your oncology trials. Learn how agile configuration and right-sized documentation keep Phase I studies on track during frequent protocol amendments.
-
24/7 Cell & Gene Control Tower Provides Agile Solution For Critical Shipments
Get an overview of a successful re-route of six critical shipments to the UK and Spain from Amsterdam used to deliver CAR-T drug products to treat non-Hodgkin’s lymphoma cancer patients.
-
3 Study Areas Where Your IRT Vendor Should Do More
Find out how advanced IRT systems now support diverse trial designs and how the expertise of RTSM vendors is crucial for tailoring solutions to trial needs and providing ongoing support.
- What Clinical Wishes Supply Did Better – And How To Close The Gap: Part 1 – The Cost Of Late Involvement
- From Invisible to Integral: Inviting Clinical Supply Expertise to the Planning Table
- Invisible Yet Accountable: How Clinical Supply Pressures Build Strategic Leaders
- Decision Authority And Direction — The Gap In Deviation Planning
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.